A groundbreaking vaccine showing promise in clinical trials has received praise from women whose lives have been devastated by breast cancer. Marie Apke, who lost her grandmother, mother, and sister to the disease, is hopeful that the vaccine being developed by the Cleveland Clinic could eliminate breast cancer within the next decade. Ms Apke, who carries a gene mutation that significantly increases her risk of developing breast cancer, expressed her desire for the vaccine to spare others from experiencing the pain she has endured. She believes that the vaccine has the potential to save lives and enable women like her sisters and mother to continue making valuable contributions to the world.
Similarly, Maria Lewis, who tragically lost her mother and niece to breast cancer, also expressed excitement about the vaccine’s potential to combat one of the deadliest forms of the disease. As someone who has personally battled breast cancer, Mrs. Lewis eagerly supports any preventative measures that could help others and potentially save lives.
Breast cancer is the most commonly diagnosed cancer among women in the US and the second leading cause of death, after lung cancer. While death rates are slowly declining, the number of fatalities remains significant. Improved screening techniques have led to recommendations for earlier screenings, starting at age 40 rather than 50.
The vaccine being trialed at the Cleveland Clinic targets a specific protein called α-lactalbuminm, which is present during lactation and breast cancer formation. By training the immune system to destroy cells producing this protein, the vaccine aims to prevent the formation and proliferation of cancer cells. Currently, the vaccine is being tested on those who have previously had triple-negative breast cancer, one of the most challenging forms of the disease. However, there is hope that it will eventually be administered to healthy individuals as a preventative measure, potentially making it the first of its kind. Dr. Kumar, the CEO of Anixa Biosciences, the company developing the vaccine, envisions its success leading to the eradication of breast cancer, much like polio and smallpox.
Marie Apke’s family has been profoundly impacted by breast cancer, with several members falling victim to the disease. After undergoing a double mastectomy to reduce her risk, Apke recognizes the importance of preventive measures, such as this vaccine, in minimizing suffering and loss.
Maria Lewis shares a similar sentiment, having also experienced the devastating impact of breast cancer within her family. Determined to see her children grow up and live fulfilling lives, Lewis is ready to embrace any advancements that can offer hope and protection against the disease.
The vaccine, developed over two decades, has been administered to 15 patients in remission from triple-negative breast cancer at the Cleveland Clinic. Thus far, none of these patients have experienced a recurrence. If successful, the vaccine could potentially eliminate triple-negative breast cancer within the next seven years. This particular form of breast cancer accounts for a small percentage of cases but is incredibly challenging to treat.
By sharing their stories and advocating for the effectiveness of this vaccine, Marie Apke and Maria Lewis hope that it will become a powerful tool in combatting breast cancer and preventing unnecessary suffering. They envision a world where women can live without the constant fear of this devastating disease and where the loss of loved ones can be avoided, allowing them to continue making positive contributions to society.
Denial of responsibility! VigourTimes is an automatic aggregator of Global media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, and all materials to their authors. For any complaint, please reach us at – [email protected]. We will take necessary action within 24 hours.
